Should mannitol be reinstated in prevention of cisplatin-induced nephrotoxicity?

Abstract

Get full access to this article

View all access options for this article.

References

Yao

Panichpisal

Kurtzman

et al.

Cisplatin nephrotoxicity: a review. Am J Med Sci 2007; 334: 115–124.

Comité des pharmaciens du comité de l’évolution des pratiques en oncologie (CEPO). Mémo à l’attention des utilisateurs de cisplatine, Quebec, Qc, Canada, 2012, p.1.

Morgan

Buie

Savage

. The role of mannitol as a nephroprotectant in patients receiving cisplatin therapy. Ann Pharmacother 2012; 46: 276–281.

Morgan

Snavely

Wind

et al.

Rates of renal toxicity in cancer patients receiving cisplatin with and without mannitol. Ann Pharmacother 2014; 48: 863–869.

McKibbin

Cheng

Kim

et al.

Mannitol to prevent cisplatin-induced nephrotoxicity in patients with squamous cell cancer of the head and neck (SCCHN) receiving concurrent therapy. Support Care Cancer 2015; Apr;24(4): 1789–1793.

Williams

Jr Ferlas

Morales

et al.

Mannitol for the prevention of cisplatin-induced nephrotoxicity: a retrospective comparison of hydration plus mannitol versus hydration alone in inpatient and outpatient regimens at a large academic medical center. J Oncol Pharm Pract 2016; Jun 27. pii: 1078155216656927.

Lobo

Stanga

Simpson

et al.

Dilution and redistribution effects of rapid 2-litre infusions of 0.9% (w/v) saline and 5% (w/v) dextrose on haematological parameters and serum biochemistry in normal subjects: a double-blind crossover study. Clin Sci (Lond) 2001; 101: 173–179.

Oka

Kimura

Suzumura

et al.

Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study. BMC Pharmacol Toxicol 2014; 15: 70–70.

Yoshida

Niho

Toda

et al.

Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study. Jpn J Clin Oncol 2014; 44: 346–354.

10.

Ozkok

Edelstein

. Pathophysiology of cisplatin-induced acute kidney injury. Biomed Res Int 2014; 2014: 967826–967826.

11.

Mehta

Kellum

Shah

et al.

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31–R31.

12.

U.S. Departement of Health and Human services, National Institutes of Health and National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). Version 4.03. Washington, D.C., USA: U.S. Departement of Health and Human services, National Institutes of Health and National Cancer Institute, 2010.